Drug Trial Radar · NCT01552915
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Last checked: Nov 20, 2026Latest source record: Jun 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
464
Actual
Start
Apr 17, 2012
Primary completion
Jan 22, 2014
Study completion Jan 22, 2014
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Mar 13, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).
Conditions
- Attention-deficit/Hyperactivity Disorder
Interventions
Lisdexamfetamine dimesylateDrug
Daily oral dosing in the AM of optimized dose, ranging from 30- 70 mg. 5 week dose optimization, 3 week dose maintenance
Methylphenidate HydrochlorideDrug
Daily oral dosing in the AM of optimized dose, ranging from 18-72 mg. 5 week dose optimization, 3 week dose maintenance
PlaceboDrug
Daily oral dosing in the AM for 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 8Time frame: Baseline and week 8
Locations
79 sites in 1 country. Site status is shown where the registry gives one.
Melmed Center
Scottsdale, Arizona
Clinical Study Centers, LLC
Little Rock, Arkansas
Synergy Clinical Research Center
National City, California
Pacific Clinical Research Medical Group
Orange, California
SDS Clinical Trials, Inc.
Orange, California
Peninsula Research Associates, Inc.
Rolling Hills Estates, California
PCSD - Feighner Research
San Diego, California
University of California, San Francisco
San Francisco, California
Neuropsychiatric Research Center of Orange County
Santa Ana, California
Elite Clinical Trials
Wildomar, California
MCB Clinical Research Centers, LLC
Colorado Springs, Colorado
Florida Clinical Research Center, LLC
Bradenton, Florida
Sarkis Clinical Trials
Gainesville, Florida
Amedica Research Institute
Hialeah, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Fidelity Clinical Research, Inc.
Lauderhill, Florida
Florida Clinical Research Center, LLC
Maitland, Florida
Scientific Clinical Research, Inc.
Miami, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Compass Research, LLC
Orlando, Florida
Stedman Clinical Trials
Tampa, Florida
Janus Center for Psychiatric Research
West Palm Beach, Florida
Atlanta Institute of Medicine and Research
Atlanta, Georgia
Capstone Clinical Research
Libertyville, Illinois
AMR Baber Research Group, Inc.
Naperville, Illinois
AMR Conventions Research
Naperville, Illinois
American Medical Research, Inc
Oak Brook, Illinois
Advocate Hope Children's Hospital
Oak Lawn, Illinois
Neuroscience Research Institute, Inc
Oak Park, Illinois
Psychiatric Associates
Overland Park, Kansas
University of Kentucky
Lexington, Kentucky
Four Rivers Clinical Research
Paducah, Kentucky
Neuroscientific InSights
Rockville, Maryland
Marc Hertzman MD, PC
Rockville, Maryland
Rochester Center for Behavioral Medicine
Rochester Hills, Michigan
Clinical Neurophysiology Services, PC
Sterling Heights, Michigan
Behavioral Medical Center - Troy
Troy, Michigan
Precise Research Centers
Flowood, Mississippi
Comprehensive Psychiatric Associates
Gladstone, Missouri
St Charles Psychiatric Associates
Saint Charles, Missouri
Showing 40 of 79 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.